openPR Logo
Press release

Rent Hike to Drive Demand for NRAS Property

03-04-2011 09:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Onyx

Rental price increases of up to 7% are anticipated for Australia’s residential property market and are likely to increase demand for National Rental Affordability Scheme (NRAS) properties from both tenants and investors.

Independent market analyst RP Data recently predicted increasing rent prices for the coming year. Rents in Australian capital cities increased by 1.4 per cent during the last three months of 2010 and rose by 4.2 per cent during last year.

According to Ruby Janssen, General Manager, Onyx Domain, the discounted rents offered by NRAS will be in great demand as rents rise through 2011 with tenants seeking relief from increasing prices.

“Rising rental yields will mean that property investors are likely to flock to NRAS properties in 2011.” says Ms Janssen.

“For investors, market rental increases will absorb much of the 20% reduction in rent they offer to tenants as part of NRAS so the investment return is improved. Investors will also be keen on the high tenant demand for their property because it offers more choice of quality tenants and a lower vacancy rate.”

As population growth in Victoria, and particularly Melbourne, continues to be strong, there is increasing competition for rental properties. This drives rental prices up, in turn making it harder for renters to become owner-occupiers, and thus keeping more people in the rental market, further increasing competition.

This phenomenon is supported by evidence from housing purchase statistics. The latest housing finance data from the Australian Bureau of Statistics demonstrates that last November Victorian first home buyers totaled just 16.3% of all owner-occupier purchasers – the lowest proportion of first-home buyers since May 2004.

This is great news for property investors for a number of reasons. Firstly, there is the obvious benefit of increased rental yield from investment properties. Secondly, a competitive rental market means that vacancy rates will remain low and you won’t have an empty property sitting on your hands for extended periods of time. Finally, it means that landlords will have a great selection of tenants to choose from and can afford to be selective in their choice of tenant.

High rental yields and a tight rental market are great for NRAS investments too. As you may or may not know, owners of NRAS approved properties agree to rent their property at 20% below market rent to eligible tenants in return for generous government tax free incentive payments. One of the great things about the NRAS scheme is that the rental for the property is genuinely held in line with the market rental value of similar properties. This means that as rental prices increase, so will the rents paid by NRAS tenants – just with a 20% reduction applied.

Furthermore, as rental prices increase, tenants are increasingly on the outlook for a good value rental property. NRAS properties, with their 20% reduction in rental price, will become even more attractive to eligible tenants. This means that NRAS property investors can expect to have even lower vacancy rates than normal residential property investors. All in all, it’s a great time to take advantage of the benefits offered by the NRAS scheme.

Onyx is a property investment services company specializing in NRAS property investments. Onyx sources property opportunities and assists investors in obtaining mortgage finance and conveyancing services. Onyx has recently made available NRAS approved apartment properties in the Melbourne CBD, right in the heart of where the greatest rent increases are expected.

Suite 1
1463 Malvern Rd
Glen Iris 3146
Australia

Ph: 1300 1400 15
E: media@onyx.net.au
W: http://onyx.net.au

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rent Hike to Drive Demand for NRAS Property here

News-ID: 165039 • Views:

More Releases from Onyx

Melbourne Property Investors Embrace Docklands Serviced Apartments
Melbourne Property Investors Embrace Docklands Serviced Apartments
A host of new opportunities are opening up for investors in Melbourne’s booming Docklands precinct, property investment services company Onyx announced today. In particular, serviced apartments are proving to be a particularly strong investment choice for investors wanting a better return on investment than is available from traditional residential properties. Serviced apartments can deliver a return that is 2-4% higher than that available from other property investment models. Current serviced
Savvy Homeowners Can Beat the Rate Rise with Fixed Rate Loans
Melbourne 18.10.2010 Current and prospective mortgage holders who act fast have an opportunity to avoid impending interest rate rises by locking in a 6.73% fixed rate home loan for the next twelve months, property services and mortgage management company Onyx announced today. This fixed rate is 0.26%-0.46% below the fixed rate advertised by the major banks. Finance industry analysts are tipping an interest rate rise to occur in the next few

More Releases for NRAS

Autoimmune Disease Diagnostics Market| Key Players are Bio-Rad Laboratories, bio …
Rising prevalence of autoimmune disorders such as rheumatoid arthritis, Hashimoto’s thyroiditis, type 1 diabetes and Grave’s disease will drive the global autoimmune disease diagnostics market. Growing patient awareness levels pertaining to autoimmune diseases due to the launch of national awareness campaigns will further fuel industry expansion. Presence of favorable government initiatives such as The Cooperative Study Group for Autoimmune Disease Prevention (CSGADP) and NIH’s HLA Region Genetics in Immune-Mediated Diseases Consortium
Bio-Rad Laboratories, bioMérieux, Profiled in Autoimmune Disease Diagnostics Ma …
Autoimmune Disease Diagnostics Market size is set to exceed USD 16 billion by 2024; according to a new research report by Global Market Insights, Inc. Rising prevalence of autoimmune disorders such as rheumatoid arthritis, Hashimoto’s thyroiditis, type 1 diabetes and Grave’s disease will drive the global autoimmune disease diagnostics market. Growing patient awareness levels pertaining to autoimmune diseases due to the launch of national awareness campaigns will further fuel industry expansion. Presence
In depth analysis on Autoimmune Disease Diagnostics| Key Players are Bio-Rad Lab …
Advancement in technology such as lab automation developed to cater the need of increasing diagnostic procedures is another growth rendering driver. Moreover, favorable research funding programs conducted by various organizations and NIH to reduce cost burden for these diseases will favor industry expansion. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/618 Localized autoimmune disease diagnostics held higher market share in 2016 and should show a similar trend over the forecast
Medikonia Appointed as AmoyDx Distributor in Hong Kong and Macau
Hong Kong, 29/01/2018 With the arrival of the first KRAS/NRAS Mutations Detection Kits at Hong Kong port, Medikonia Limited (Medikonia) announces today it has signed distributorship agreement with Amoy Diagnostics Co., Ltd. (AmoyDx) to bring its wide range of molecular diagnostics tests to Hong Kong and Macau. “Precision medicine is a promising industry; it will help patients get right medications based on his/her genetic profile, saving dramatically for healthcare” said Joe Lai,
EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung …
The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable. Amoy Diagnostics, located in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting
Amoy Diagnostics, China, Expands List of CE-marked Real-Time PCR Kits for Cancer …
Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits based on a proprietary real-time PCR technology called “ADx-ARMS” for Cancer Diagnostics. Amoy Diagnostics, headquarted in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting mutations and measuring gene expression in